NASDAQ: BEAMBeam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?
Insider buying vs selling
Have Beam Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Amy Simon | Chief Medical Officer | 2024-04-02 | 16,530 | $30.54 | $504.84kSell |
| John M. Evans | CEO | 2024-04-01 | 18,102 | $32.13 | $581.62kSell |
| Christine Bellon | Chief Legal Officer | 2024-04-01 | 3,401 | $32.12 | $109.24kSell |
| Terryann Burrell | Chief Financial Officer | 2024-04-01 | 5,446 | $32.12 | $174.93kSell |
| Amy Simon | Chief Medical Officer | 2024-04-01 | 7,157 | $32.13 | $229.95kSell |
| Giuseppe Ciaramella | President | 2024-04-01 | 4,534 | $32.12 | $145.63kSell |
| John M. Evans | CEO | 2024-03-28 | 60,000 | $33.86 | $2.03MSell |
| Fmr LLC | Insider | 2024-02-14 | 45,677 | $31.34 | $1.43MSell |
| Fmr LLC | Insider | 2024-02-14 | 854,323 | $30.51 | $26.07MSell |
| Fmr LLC | Insider | 2024-02-13 | 1,155 | $30.93 | $35.72kSell |
BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BEAM insiders and whales buy or sell their stock.
BEAM Shareholders
What type of owners hold Beam Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ark Investment Management LLC | 11.50% | 9,393,889 | $220.47M | Institution |
| Vanguard Group Inc | 8.77% | 7,164,876 | $168.16M | Institution |
| Fmr LLC | 8.34% | 6,810,451 | $159.84M | Insider |
| Blackrock Inc | 8.16% | 6,662,043 | $156.36M | Institution |
| Fmr LLC | 7.57% | 6,180,322 | $145.05M | Institution |
| State Street Corp | 5.65% | 4,616,358 | $108.35M | Institution |
| Morgan Stanley | 5.12% | 4,184,342 | $98.21M | Institution |
| Farallon Capital Management LLC | 5.03% | 4,105,753 | $96.36M | Institution |
| Robert Nelsen | 4.33% | 3,535,572 | $82.98M | Insider |
| Temasek Holdings Private Ltd | 3.77% | 3,076,117 | $72.20M | Institution |
BEAM vs Biotech Stocks
Beam Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.